KITO, 5 March – RIA Novosti. The movement of indigenous peoples of Ecuador intends to provide their communities with the Russian vaccine against coronavirus Sputnik V, President of the Movement of Indigenous Peoples of the Cotopaxi province Leonidas Isa told RIA Novosti. “Yesterday we spoke with representatives of the Russian Embassy in Quito, and next week we will have a meeting with the director Agency for regulation, control and sanitary supervision Arcsa to find out why the authorization process (vaccines – ed.) Is not progressing, “said Leonidas Isa.
According to him, the mayors of the cities of Cayambé, Guaranda and Cotopaxi were present at the meeting with Russian diplomats, since the indigenous peoples' movement intends to promote the issuance of a permit for the import of Sputnik V together with the Association of Ecuadorian Municipalities.
Isa noted that the need of the indigenous peoples of Ecuador for a vaccine at the initial stage is 500 thousand doses, this will allow to include 40% of the indigenous population in immunization, although the Association of Municipalities will negotiate quotas for different regions.
The Indigenous Movement of Ecuador also intends to seek international assistance in purchasing vaccines for its population.
“We will do everything we can, on our part, from the local authorities, and we will put pressure on the state so that the government does its duty and ensure that the entire Ecuadorian population is covered,” added Leonidas Isa.
Earlier, Ecuadorian presidential candidate Andres Araus told RIA Novosti that he was pleased with the negotiations on the purchase of the Russian vaccine against the Sputnik V coronavirus without specifying the volume of the discussed supplies.
The government of incumbent President Lenin Moreno has reached agreements on the supply of vaccines with Pfizer, AstraZeneca, Jonhson & Johnson, Moderna and the international COVAX mechanism. To date, the Pfizer / BioNTech coronavirus vaccine has been delivered to the country in four small batches, with a total of 73,710 doses of the drug. Vaccination of priority populations began on 21 January.